Total Payments
$7,717
2024 Payments
$53.84
Companies
21
Transactions
149
Medicare Patients
15,555
Medicare Billing
$880,669
Payment Breakdown by Category
Food & Beverage$4,311 (55.9%)
Travel$3,406 (44.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,311 | 142 | 55.9% |
| Travel and Lodging | $3,406 | 7 | 44.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,904 | 32 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,317 | 18 | $0 (2019) |
| Amgen Inc. | $366.81 | 16 | $0 (2019) |
| PFIZER INC. | $304.48 | 12 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $239.38 | 11 | $0 (2020) |
| Amarin Pharma Inc. | $223.97 | 9 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $167.88 | 10 | $0 (2022) |
| Edwards Lifesciences Corporation | $163.08 | 2 | $0 (2019) |
| Gilead Sciences, Inc. | $155.87 | 7 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $127.57 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53.84 | 2 | Boston Scientific Corporation ($53.84) |
| 2023 | $104.63 | 2 | Medtronic, Inc. ($87.55) |
| 2022 | $88.82 | 4 | Amarin Pharma Inc. ($43.36) |
| 2021 | $151.02 | 5 | PFIZER INC. ($112.88) |
| 2020 | $197.07 | 9 | PFIZER INC. ($79.55) |
| 2019 | $817.86 | 29 | Boston Scientific Corporation ($224.44) |
| 2018 | $4,550 | 52 | BOSTON SCIENTIFIC CORPORATION ($2,217) |
| 2017 | $1,753 | 46 | Medtronic Vascular, Inc. ($654.03) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $28.59 | General |
| 06/24/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.25 | General |
| 12/18/2023 | Medtronic, Inc. | PulseSelect (Device) | Food and Beverage | In-kind items and services | $87.55 | General |
| Category: Ablation | ||||||
| 02/24/2023 | Boston Scientific Corporation | AngioJet Ultra 5000A (Device) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: AngioJet_PI | ||||||
| 10/18/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/13/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $43.36 | General |
| Category: Cardiovascular | ||||||
| 04/15/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/18/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: Cardiovascular | ||||||
| 09/29/2021 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/13/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $37.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/29/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $37.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/18/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $37.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $39.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/08/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/04/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Cardiovascular | ||||||
| 05/15/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardiovascular | ||||||
| 04/19/2020 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/12/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/24/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $35.28 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/17/2020 | PORTOLA PHARMACEUTICALS, LLC | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 01/31/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiovascular | ||||||
| 12/19/2019 | Boston Scientific Corporation | EMBLEM (Device) | Food and Beverage | In-kind items and services | $64.04 | General |
| Category: TACHY | ||||||
| 12/06/2019 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/02/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $44.10 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,300 | 6,951 | $741,418 | $211,754 |
| 2022 | 19 | 4,053 | 7,655 | $740,805 | $220,811 |
| 2021 | 21 | 4,318 | 8,313 | $742,717 | $230,514 |
| 2020 | 25 | 3,884 | 7,042 | $638,633 | $217,590 |
Total Patients
15,555
Total Services
29,961
Medicare Billing
$880,669
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 649 | 1,374 | $97,554 | $28,233 | 28.9% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 833 | 1,767 | $97,185 | $26,984 | 27.8% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 35 | 35 | $90,685 | $25,821 | 28.5% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 243 | 862 | $90,510 | $22,437 | 24.8% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 163 | 911 | $55,571 | $16,897 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 169 | $40,729 | $14,576 | 35.8% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 34 | 34 | $61,948 | $12,870 | 20.8% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 28 | 29 | $34,742 | $11,288 | 32.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 189 | 412 | $35,844 | $10,954 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 77 | 81 | $26,163 | $10,153 | 38.8% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 14 | 15 | $28,950 | $9,772 | 33.8% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 82 | 251 | $15,562 | $4,598 | 29.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 502 | 642 | $12,196 | $4,020 | 33.0% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 12 | 12 | $11,796 | $2,868 | 24.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 173 | 219 | $8,103 | $2,223 | 27.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 34 | $5,576 | $2,082 | 37.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $6,370 | $1,746 | 27.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 25 | 25 | $11,300 | $1,341 | 11.9% |
| 93285 | Programming of cardiac rhythm monitor system | Office | 2023 | 20 | 20 | $2,360 | $894.90 | 37.9% |
| 93623 | Programming of heart rhythm stimulation after drug infusion | Facility | 2023 | 14 | 14 | $5,320 | $889.56 | 16.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 13 | 13 | $2,054 | $802.88 | 39.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 18 | $900.00 | $303.28 | 33.7% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2022 | 44 | 44 | $114,004 | $38,928 | 34.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 669 | 1,280 | $90,880 | $26,006 | 28.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 874 | 1,641 | $90,255 | $25,609 | 28.4% |
About Dr. Christopher Rogers, D.O
Dr. Christopher Rogers, D.O is a Clinical Cardiac Electrophysiology healthcare provider based in Wyomissing, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285626226.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Rogers, D.O has received a total of $7,717 in payments from pharmaceutical and medical device companies, with $53.84 received in 2024. These payments were reported across 149 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,311).
As a Medicare-enrolled provider, Rogers has provided services to 15,555 Medicare beneficiaries, totaling 29,961 services with total Medicare billing of $880,669. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Other Specialties Cardiovascular Disease
- Location Wyomissing, PA
- Active Since 08/16/2005
- Last Updated 01/22/2021
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1285626226
Products in Payments
- GENERAL THERAPIES (Device) $1,977
- Arctic Front (Device) $1,642
- Micra (Device) $634.12
- VIGILANT (Device) $396.19
- ELIQUIS (Drug) $338.80
- Corlanor (Drug) $243.98
- LifeVest (Device) $239.38
- Vascepa (Drug) $223.97
- XARELTO (Drug) $219.87
- WATCHMAN (Device) $173.97
- ENTRESTO (Drug) $167.88
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $163.08
- Repatha (Biological) $122.83
- Livalo (Drug) $119.13
- EPI-SENSE GUIDED COAGULATION DEV (Device) $90.58
- PulseSelect (Device) $87.55
- EMBLEM (Device) $86.47
- WATCHMAN DEVICE (Device) $79.52
- PRALUENT (Biological) $73.75
- GENERAL - THERAPIES (Device) $60.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.